ONVO......

Have they passed full FDA approval yet, or is this still a company in trials? If it is still in trials, I wouldn't invest that much right now. Most biotechs fail; those that don't often skyrocket. So unless you have a good background to understand trial data, don't use too much capital on any one biotech. Personally, I would rather play with biotechs using options.

It's a long story! I would advise you do your own DD! The standard 2d livers and RAT livers give you false positive and negatives on liver tox! Which in return cost company's major money in lawsuits down the road! Not to mention the time it takes to detect! Organovo produces a 3D liver patch that lives more than 40 days and can detect within the first 7 days! They can use stem cells from the actual patient and do dose test to see how that patient reacts to a certain drug and in what doses it reacts! This is just the tip of the iceberg so I recommend you read and do you own DD to fully understand! Btw they have enough cash on hand to last 2+ years and they are getting revenue from the liver now and rolling out the kidney patch this years with customers waiting!

Is the period on your keyboard broken, or do you just really like exclamation marks?

I get caught up in the moment.